Biogen drops Alzheimer’s drug Aduhelm to focus on Leqembi, others
The Biogen headquarters in Cambridge, Massachusetts, on Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it ...
The Biogen headquarters in Cambridge, Massachusetts, on Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it ...
Eisai on Wednesday said an injectable version of the Alzheimer's drug Leqembi showed promising initial results in a clinical trial, ...
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen on Tuesday said it expects to cut approximately 1,000 jobs, or ...
Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University ...
The Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, and Medicare said it would ...
On Thursday, the Food and Drug Administration gave full approval to the drug Leqembi for patients who are in the ...
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval.
The Food and Drug Administration on Thursday approved the Alzheimer's treatment Leqembi, a pivotal decision that will expand access to ...
The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on Jan. 20, 2023.Eisai | ReutersThe ...
Tek Image/science Photo Library | Science Photo Library | Getty ImagesJapanese drugmaker Eisai expects the Food and Drug Administration to ...